In parallel to carcinoma, SOX2 is a critical oncogene for neural progenitor cell–derived cancers, such as glioblastoma and medulloblastoma, where it sustains cancer stem cells (48, 49). This evidence concerns the gene SOX2 and medulloblastoma.